MD
$28.08+2.86%
Pediatrix Medical Group Inc.Stock · HealthcareRussell 2000 · 0.07% of IWMUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
MD financial statements
The full income statement, balance sheet, and cash-flow statement for Pediatrix Medical Group Inc. (MD), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 85.9M2024-09 85.9M2024-12 85.8M2025-03 85.9M2025-06 87.1M2025-09 85.9M2025-12 83.0M2026-03 82.1M2026-06 81.3M-5.4% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 1.91B-4.9% | 2.01B+0.9% | 1.99B+1.1% | 1.97B+3.2% | 1.91B+10.2% | |
| 1.71B-18.1% | 2.08B+4.7% | 1.99B+10.4% | 1.80B+5.3% | 1.71B+4.4% | ||
| Selling, general & administrative | 241M+1.0% | 238M+4.8% | 228M-1.7% | 231M-12.1% | 263M+5.8% | |
| General & administrative | 241M+1.0% | 238M+4.8% | 228M-1.7% | 231M-12.1% | 263M+5.8% | |
| Restructuring | 22.3M-65.3% | 64.3M+2795.9% | 2.22M-91.9% | 27.3M+23.6% | 22.1M-70.1% | |
| Amortization of intangibles | 5.70M-19.7% | 7.10M+26.8% | 5.60M-12.5% | 6.40M-20.0% | 8.00M+5.3% | |
| Operating income | 209M+403.9% | -68.7M-1038.6% | 7.32M-95.8% | 173M-14.9% | 203M+106.8% | |
| Interest expense | 36.0M-11.7% | 40.7M-3.2% | 42.1M+6.0% | 39.7M-42.2% | 68.7M-37.8% | |
| Other non-operating income | 7.62M+123.4% | -32.6M+41.4% | -55.7M+39.0% | -91.3M-34.9% | -67.7M+25.6% | |
| Equity-method income | 3.63M+55.0% | 2.34M+14.0% | 2.06M+19.5% | 1.72M-9.9% | 1.91M+20.6% | |
| Pre-tax income | 216M+313.6% | -101M-109.6% | -48.4M-159.4% | 81.4M-39.8% | 135M+1791.8% | |
| Income tax | 51.0M+2346.7% | -2.27M-118.9% | 12.0M-35.9% | 18.8M-31.0% | 27.2M+62.8% | |
| 165M+266.9% | -99.1M-64.0% | -60.4M-191.1% | 66.3M-49.3% | 131M+116.4% | ||
| Discontinued operations | — | 0.00 | 0.00-100.0% | 3.77M-83.6% | 22.9M+102.9% | |
| Net income to non-controlling interest | — | 0.00 | 0.00+100.0% | -4.00K+85.2% | -27.0K | |
| $1.94+263.0% | -$1.19-63.0% | -$0.73-192.4% | $0.79-48.4% | $1.53+116.0% | ||
| EPS (basic) | $1.97+265.5% | -$1.19-63.0% | -$0.73-192.4% | $0.79-48.7% | $1.54+116.1% | |
| Weighted-avg shares (basic) | 84.4M+1.3% | 83.3M+1.4% | 82.2M-1.5% | 83.5M-1.6% | 84.8M+1.7% | |
| Weighted-avg shares (diluted) | 85.4M+2.5% | 83.3M+1.4% | 82.2M-2.3% | 84.1M-2.0% | 85.8M+2.9% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 764M+19.4% | 640M+32.3% | 483M+13.0% | 428M-49.1% | 841M-45.7% | ||
| Cash & equivalents | 375M+63.2% | 230M+213.9% | 73.3M+645.7% | 9.82M-97.5% | 387M-65.5% | |
| Accounts receivable | 230M-11.7% | 260M-4.5% | 272M-8.2% | 297M-1.7% | 302M+24.7% | |
| Prepaid expenses | 12.6M-6.0% | 13.4M-0.9% | 13.5M-9.1% | 14.9M-19.7% | 18.5M+9.7% | |
| Other current assets | 8.88M+74.5% | 5.09M-58.7% | 12.3M-7.2% | 13.3M-29.8% | 18.9M-69.4% | |
| 2.25B+4.4% | 2.15B-3.0% | 2.22B-5.5% | 2.35B-13.8% | 2.72B-18.7% | ||
| Property, plant & equipment | 39.2M+0.0% | 39.2M-48.2% | 75.6M+3.2% | 73.3M+4.5% | 70.2M-7.9% | |
| Operating lease right-of-use | 31.1M-8.7% | 34.1M-44.7% | 61.7M+10.6% | 55.8M+8.8% | 51.3M+14.1% | |
| Goodwill | 1.26B+1.5% | 1.24B-10.2% | 1.38B-9.7% | 1.53B+1.8% | 1.51B+1.9% | |
| Intangible assets | 16.9M+45.4% | 11.6M-45.4% | 21.2M+14.9% | 18.5M-14.3% | 21.6M-19.1% | |
| Deferred tax assets | 73.9M-28.8% | 104M+1.0% | 103M-2.9% | 106M+19.9% | 88.3M+62.2% | |
| Other non-current assets | 58.2M-24.1% | 76.6M-6.8% | 82.2M-33.3% | 123M-6.0% | 131M+22.1% | |
| 459M+5.7% | 434M+11.6% | 389M-8.9% | 427M-0.1% | 427M-3.8% | ||
| Accounts payable | 37.2M-19.8% | 46.4M+34.2% | 34.6M+8.6% | 31.9M-13.1% | 36.6M-38.7% | |
| Accrued liabilities | 420M+5.2% | 399M+13.7% | 351M-6.3% | 374M-5.0% | 394M-6.9% | |
| Short-term & current debt | 26.8M+30.5% | 20.5M+37.8% | 14.9M+0.1% | 14.9M+498.3% | 2.49M | |
| Current lease liability | 11.6M-8.8% | 12.7M-39.7% | 21.1M-2.4% | 21.6M+9.7% | 19.7M+4.0% | |
| Finance lease liability (current) | 1.81M+0.6% | 1.79M-25.6% | 2.41M+0.6% | 2.40M-3.7% | 2.49M+12.2% | |
| 1.38B-0.5% | 1.39B+1.2% | 1.37B-5.9% | 1.46B-20.2% | 1.83B-29.8% | ||
| Long-term debt | 571M-6.7% | 611M-1.8% | 622M-2.4% | 637M-35.6% | 990M-41.8% | |
| Non-current lease liability | 25.7M-19.6% | 31.9M-32.4% | 47.2M+6.8% | 44.2M+6.8% | 41.4M+1.0% | |
| Operating lease liability (total) | 37.3M-16.5% | 44.6M-34.6% | 68.3M+3.8% | 65.8M+7.7% | 61.1M+2.0% | |
| Finance lease liability (total) | 3.38M-36.6% | 5.34M-42.2% | 9.24M-17.0% | 11.1M-21.5% | 14.2M+27.5% | |
| Finance lease liability | 1.58M-55.5% | 3.55M-48.1% | 6.83M-21.8% | 8.73M-25.3% | 11.7M+31.3% | |
| Deferred tax liabilities | 57.0M+66.5% | 34.2M-0.2% | 34.3M+2.0% | 33.6M-18.8% | 41.4M-32.9% | |
| Other non-current liabilities | 30.3M-7.8% | 32.9M+7.6% | 30.6M-22.5% | 39.4M-6.9% | 42.3M-6.6% | |
| 866M+13.2% | 765M-9.9% | 849M-4.8% | 892M-0.5% | 896M+19.9% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 830K-3.4% | 859K+2.3% | 840K+1.3% | 829K-4.1% | 864K+0.9% | |
| Additional paid-in capital | 948M-6.5% | 1.01B+1.4% | 1000M+1.7% | 984M-6.3% | 1.05B+2.0% | |
| Retained earnings | -83.2M+66.5% | -249M-66.3% | -149M-67.8% | -89.1M+42.7% | -155M+45.7% | |
| Accumulated other comprehensive income | 610K+157.0% | -1.07M+51.6% | -2.21M+40.7% | -3.73M-383.6% | 1.32M-62.7% | |
| Non-controlling interest | — | — | — | 0.00-100.0% | 205K-11.6% | |
| Total equity incl. non-controlling | 866M+13.2% | 765M-9.9% | 849M-4.8% | 892M-0.6% | 897M+19.9% | |
| Total liabilities & equity | 2.25B+4.4% | 2.15B-3.0% | 2.22B-5.5% | 2.35B-13.8% | 2.72B-18.7% | |
| Common shares issued | 83.0M-3.4% | 85.9M+2.2% | 84.0M+1.3% | 82.9M-4.0% | 86.4M+0.0% | |
| Common shares outstanding | 83.0M-3.4% | 85.9M+2.2% | 84.0M+1.3% | 82.9M-4.0% | 86.4M+1.0% | |
| Shares outstanding (cover) | 83.0M-3.3% | 85.8M+2.0% | 84.1M+1.3% | 83.0M-4.0% | 86.5M+1.0% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 271M+31.2% | 207M+50.4% | 137M-17.7% | 167M+117.5% | 76.7M-62.5% | ||
| Depreciation & amortization | 21.8M-32.3% | 32.2M-10.9% | 36.2M+1.5% | 35.6M+10.9% | 32.1M+13.0% | |
| Intangible amortization | 5.70M-19.7% | 7.10M+26.8% | 5.60M-12.5% | 6.40M-20.0% | 8.00M+5.3% | |
| Share-based compensation | 18.0M+52.0% | 11.9M-3.7% | 12.3M-23.6% | 16.1M-15.0% | 19.0M-51.4% | |
| Deferred income taxes | 52.2M+2550.0% | -2.13M-165.8% | 3.24M+114.2% | -22.8M+27.1% | -31.2M-186.1% | |
| Change in receivables | -30.6M-196.9% | -10.3M+60.8% | -26.3M-574.0% | 5.54M-92.4% | 72.7M+291.7% | |
| -18.3M+48.3% | -35.4M+26.5% | -48.2M+15.4% | -57.0M-7.3% | -53.1M-106.5% | ||
| Capital expenditure | 18.5M-16.2% | 22.0M-33.9% | 33.3M+12.2% | 29.7M-7.9% | 32.2M+12.0% | |
| Free cash flow | 253M+36.9% | 185M+77.5% | 104M-24.2% | 137M+208.5% | 44.5M-74.7% | |
| Acquisitions | 23.2M+184.0% | 8.17M+22.5% | 6.67M-76.3% | 28.2M-5.9% | 29.9M+1245.2% | |
| Purchases of investments | 29.9M-53.8% | 64.5M+102.4% | 31.9M+83.9% | 17.3M+15.2% | 15.1M-75.7% | |
| Sales/maturities of investments | — | 52.5M+129.2% | 22.9M+35.6% | 16.9M+2.4% | 16.5M-50.7% | |
| Other investing activities | 3.46M+150.7% | -6.83M-747.0% | -807K | — | — | |
| -107M-642.1% | -14.5M+43.7% | -25.7M+94.7% | -488M+35.9% | -760M-18180.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00-100.0% | 650M | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 3.18M-12.5% | 3.64M-25.9% | 4.91M-9.0% | 5.40M-21.3% | 6.85M-2.2% | |
| Common stock repurchased | 86.7M+4990.0% | 1.70M+85.3% | 919K-99.0% | 88.5M+1775.6% | 4.72M-44.4% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | -63.0K-146.7% | 135K+101.5% | -8.77M-193.8% | 9.35M+1469.3% | 596K | |
| Net change in cash | 145M-7.3% | 157M+147.0% | 63.4M+116.8% | -378M+48.7% | -736M-172.5% | |
| Interest paid | 34.4M-14.1% | 40.0M-5.4% | 42.3M-63.6% | 116M+34.3% | 86.5M-21.7% | |
| Income taxes paid | 1.72M-63.3% | 4.67M-84.8% | 30.8M+14.6% | 26.9M-50.8% | 54.7M+297.0% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.78B+57.7% | 1.13B+44.1% | 781M-36.7% | 1.23B-47.5% | 2.35B+12.0% | |
| P/E | 10.7× | — | 8.4×-43.0% | 14.7×-18.4% | 18.0× | |
| P/S | 0.9×+65.8% | 0.6×+44.0% | 0.4×-38.4% | 0.6×-48.8% | 1.2×+1.6% | |
| P/B | 2.1×+39.3% | 1.5×+82.4% | 0.8×-43.8% | 1.4×-45.2% | 2.6×-6.6% | |
| P/FCF | 7.0×+15.2% | 6.1×+4.2% | 5.9×-57.9% | 13.9×-73.7% | 52.9×+342.5% | |
| Earnings yield | 9.3% | — | 12.0%+75.5% | 6.8%+22.5% | 5.6% | |
| FCF yield | 14.2%-13.2% | 16.4%-4.0% | 17.1%+137.7% | 7.2%+279.9% | 1.9%-77.4% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: MD’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MD filings on SEC EDGAR → Not investment advice.